2018年NICE咽喉痛(急性)抗菌药物处方指南解读(一)—抗菌药物处方选用和自我保健方案

2018-07-20 中国全科医学.2018.21(21):2521-2524.

咽喉痛是耳鼻咽喉科常见疾病,抗菌药物治疗是临床医生的主要手段。抗菌药物选用的单一性和疗程的不规范导致了越来越多的不合理用药的发生。咽喉痛(急性)抗菌药物处方是英国国家卫生与临床优化研究所(NICE)2018 年1 月最新发布的指南,此指南详细制定了治疗急性咽喉痛的抗菌药物处方策略,其目的是限制抗菌药物的应用,减少抗菌药物耐药性发生。因其引用的2014 的研究报告中60% 的患者均是咽喉痛,故此指南

中文标题:

2018年NICE咽喉痛(急性)抗菌药物处方指南解读(一)—抗菌药物处方选用和自我保健方案

发布机构:

发布日期:

2018-07-20

简要介绍:

咽喉痛是耳鼻咽喉科常见疾病,抗菌药物治疗是临床医生的主要手段。抗菌药物选用的单一性和疗程的不规范导致了越来越多的不合理用药的发生。咽喉痛(急性)抗菌药物处方是英国国家卫生与临床优化研究所(NICE)2018 年1 月最新发布的指南,此指南详细制定了治疗急性咽喉痛的抗菌药物处方策略,其目的是限制抗菌药物的应用,减少抗菌药物耐药性发生。因其引用的2014 的研究报告中60% 的患者均是咽喉痛,故此指南对咽喉痛的症状和治疗所给出的抗菌药物选用标准清晰明确,非常适合耳鼻咽喉科和全科医生使用。本文就此指南中急性咽喉痛抗菌药物的选用和自我保健方案,结合相关文献进行复习。 

作者: 煤炭总医院耳鼻咽喉科 韦新法 吴慧莉 冉小军

拓展指南:咽喉相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018年NICE咽喉痛(急性)抗菌药物处方指南解读(一)—抗菌药物处方选用和自我保健方案)] GetToolGuiderByIdResponse(projectId=1, id=792f61c001619e2c, title=2018年NICE咽喉痛(急性)抗菌药物处方指南解读(一)—抗菌药物处方选用和自我保健方案, enTitle=, guiderFrom=中国全科医学.2018.21(21):2521-2524., authorId=null, author=, summary=咽喉痛是耳鼻咽喉科常见疾病,抗菌药物治疗是临床医生的主要手段。抗菌药物选用的单一性和疗程的不规范导致了越来越多的不合理用药的发生。咽喉痛(急性)抗菌药物处方是英国国家卫生与临床优化研究所(NICE)2018 年1 月最新发布的指南,此指南详细制定了治疗急性咽喉痛的抗菌药物处方策略,其目的是限制抗菌药物的应用,减少抗菌药物耐药性发生。因其引用的2014 的研究报告中60% 的患者均是咽喉痛,故此指南, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Jul 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>咽喉痛是耳鼻咽喉科常见疾病,抗菌药物治疗是临床医生的主要手段。抗菌药物选用的单一性和疗程的不规范导致了越来越多的不合理用药的发生。咽喉痛(急性)抗菌药物处方是英国国家卫生与临床优化研究所(NICE)2018 年1 月最新发布的指南,此指南详细制定了治疗急性咽喉痛的抗菌药物处方策略,其目的是限制抗菌药物的应用,减少抗菌药物耐药性发生。因其引用的2014 的研究报告中60% 的患者均是咽喉痛,故此指南对咽喉痛的症状和治疗所给出的抗菌药物选用标准清晰明确,非常适合耳鼻咽喉科和全科医生使用。本文就此指南中急性咽喉痛抗菌药物的选用和自我保健方案,结合相关文献进行复习。 </div> <div><br> </div>作者: 煤炭总医院耳鼻咽喉科 韦新法 吴慧莉 冉小军 <div><br> </div> 拓展指南:<strong>与<font color=red>咽喉</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=cd1c01c001a99622" title="2017 临床实践指南:应用糖皮质激素治疗咽喉痛" target=_blank>2017 临床实践指南:应用糖皮质激素治疗咽喉痛</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=1a8e31c001163af7" title="耳鼻咽喉科专业11个病种临床路径" target=_blank>耳鼻咽喉科专业11个病种临床路径</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%92%BD%E5%96%89" target=_blank>有关咽喉更多指南</a></ul>, tagList=[TagDto(tagId=7795, tagName=咽喉痛), TagDto(tagId=64437, tagName=抗菌药物处方)], categoryList=[CategoryDto(categoryId=30, categoryName=耳鼻咽喉科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8153, appHits=293, showAppHits=0, pcHits=5470, showPcHits=3206, likes=156, shares=15, comments=4, approvalStatus=1, publishedTime=Wed Jul 25 21:54:40 CST 2018, publishedTimeString=2018-07-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Jul 25 21:54:40 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 14:06:42 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018年NICE咽喉痛(急性)抗菌药物处方指南解读(一)—抗菌药物处方选用和自我保健方案)])
2018年NICE咽喉痛(急性)抗菌药物处方指南解读(一)—抗菌药物处方选用和自我保健方案
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1237451, encodeId=94dd123e451bf, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22266498213, createdName=ms4000001207897157, createdTime=Mon Aug 08 23:05:35 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951234, encodeId=4ff9951234a3, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/eee8af6365ed4d459687ebdc4a62bd09/f3de335e36844f88a4515193d097be81.jpg, createdBy=9c315473229, createdName=ms1000001818983804, createdTime=Thu Mar 25 18:05:53 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334540, encodeId=f414334540aa, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Jul 27 16:40:12 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334145, encodeId=a75333414502, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Jul 25 23:06:32 CST 2018, time=2018-07-25, status=1, ipAttribution=)]
    2022-08-08 ms4000001207897157

    谢谢分享学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1237451, encodeId=94dd123e451bf, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22266498213, createdName=ms4000001207897157, createdTime=Mon Aug 08 23:05:35 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951234, encodeId=4ff9951234a3, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/eee8af6365ed4d459687ebdc4a62bd09/f3de335e36844f88a4515193d097be81.jpg, createdBy=9c315473229, createdName=ms1000001818983804, createdTime=Thu Mar 25 18:05:53 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334540, encodeId=f414334540aa, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Jul 27 16:40:12 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334145, encodeId=a75333414502, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Jul 25 23:06:32 CST 2018, time=2018-07-25, status=1, ipAttribution=)]
    2021-03-25 ms1000001818983804

    非常好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1237451, encodeId=94dd123e451bf, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22266498213, createdName=ms4000001207897157, createdTime=Mon Aug 08 23:05:35 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951234, encodeId=4ff9951234a3, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/eee8af6365ed4d459687ebdc4a62bd09/f3de335e36844f88a4515193d097be81.jpg, createdBy=9c315473229, createdName=ms1000001818983804, createdTime=Thu Mar 25 18:05:53 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334540, encodeId=f414334540aa, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Jul 27 16:40:12 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334145, encodeId=a75333414502, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Jul 25 23:06:32 CST 2018, time=2018-07-25, status=1, ipAttribution=)]
    2018-07-27 三生有幸9135

    学习一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1237451, encodeId=94dd123e451bf, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22266498213, createdName=ms4000001207897157, createdTime=Mon Aug 08 23:05:35 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951234, encodeId=4ff9951234a3, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/eee8af6365ed4d459687ebdc4a62bd09/f3de335e36844f88a4515193d097be81.jpg, createdBy=9c315473229, createdName=ms1000001818983804, createdTime=Thu Mar 25 18:05:53 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334540, encodeId=f414334540aa, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Jul 27 16:40:12 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334145, encodeId=a75333414502, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Jul 25 23:06:32 CST 2018, time=2018-07-25, status=1, ipAttribution=)]
    2018-07-25 清风拂面

    谢谢分享学习

    0